<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1371/journal.pone.0089866</dc:identifier><dc:language>eng</dc:language><dc:creator>Almagro, P.</dc:creator><dc:creator>Martinez-Camblor, P.</dc:creator><dc:creator>Soriano, J. B.</dc:creator><dc:creator>Marin, J. M.</dc:creator><dc:creator>Alfageme, I.</dc:creator><dc:creator>Casanova, C.</dc:creator><dc:creator>Esteban, C.</dc:creator><dc:creator>Soler-Cataluña, J. J.</dc:creator><dc:creator>De-Torres, J.</dc:creator><dc:creator>Celli, B. R.</dc:creator><dc:creator>Miravitlles, M.</dc:creator><dc:title>Finding the best thresholds of FEV1and dyspnea to predict 5-year survival in COPD patients: The COCOMICS study</dc:title><dc:identifier>ART-2014-100112</dc:identifier><dc:description>Background: FEV1 is universally used as a measure of severity in COPD. Current thresholds are based on expert opinion and not on evidence. Objectives: We aimed to identify the best FEV1 (% predicted) and dyspnea (mMRC) thresholds to predict 5-yr survival in COPD patients. Design and Methods: We conducted a patient-based pooled analysis of eleven COPD Spanish cohorts (COCOMICS). Survival analysis, ROC curves, and C-statistics were used to identify and compare the best FEV1 (%) and mMRC scale thresholds that predict 5-yr survival. Results: A total of 3, 633 patients (93% men), totaling 15, 878 person-yrs. were included, with a mean age 66.4±9.7, and predicted FEV1 of 53.8% (±19.4%). Overall 975 (28.1%) patients died at 5 years. The best thresholds that spirometrically split the COPD population were: mild =70%, moderate 56-69%, severe 36-55%, and very severe =35%. Survival at 5 years was 0.89 for patients with FEV1=70 vs. 0.46 in patients with FEV1 =35% (H.R: 6; 95% C.I.: 4.69-7.74). The new classification predicts mortality significantly better than dyspnea (mMRC) or FEV1 GOLD and BODE cutoffs (all p&lt;0.001). Prognostic reliability is maintained at 1, 3, 5, and 10 years. In younger patients, survival was similar for FEV1 (%) values between 70% and 100%, whereas in the elderly the relationship between FEV1 (%) and mortality was inversely linear. Conclusions: The best thresholds for 5-yr survival were obtained stratifying FEV1 (%) by =70%, 56-69%, 36-55%, and =35%. These cutoffs significantly better predict mortality than mMRC or FEV1 (%) GOLD and BODE cutoffs.</dc:description><dc:date>2014</dc:date><dc:source>http://zaguan.unizar.es/record/63338</dc:source><dc:doi>10.1371/journal.pone.0089866</dc:doi><dc:identifier>http://zaguan.unizar.es/record/63338</dc:identifier><dc:identifier>oai:zaguan.unizar.es:63338</dc:identifier><dc:relation>info:eu-repo/grantAgreement/ES/MICINN/MTM2011-23204</dc:relation><dc:identifier.citation>PLoS One 9, 2 (2014), e89866 [7 pp]</dc:identifier.citation><dc:rights>by</dc:rights><dc:rights>http://creativecommons.org/licenses/by/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>